104554 Federal Register / Vol. 89, No. 246 / Monday, December 23, 2024 / Notices 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Alzheimer’s 

Disease Drug Development Program. 

Date: January 23, 2025. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institute on Aging, 5601 

Fishers Lane, Suite 8B, Rockville, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Mariel Jais, PharmD, 

Scientific Review Officer, National Institute 

of Aging, National Institute of Health, 5601 

Fishers Lane, Room 2E400, Rockville, MD 

20852, (301) 594–2614, mariel.jais@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: December 17, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–30555 Filed 12–20–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; R03 Medical 

Transition to Aging Research. 

Date: February 18, 2025. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institute on Aging, 5601 

Fishers Lane, Suite 8B, Rockville, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Ivan Tadeu Rebustini, 

Ph.D., Scientific Review Officer, National 

Institute of Aging, National Institute of 

Health, 5601 Fishers Lane, Room 100, 

Rockville, MD 20852, (301) 555–1212, 

ivan.rebustini@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: December 17, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–30559 Filed 12–20–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; SWAN. 

Date: February 28, 2025. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institute on Aging, 5601 

Fishers Lane, Suite 8B, Rockville, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Rajasri Roy, Ph.D., MPH, 

Scientific Review Officer, National Institute 

of Aging, National Institute of Health, 5601 

Fishers Lane, Room 100, Rockville, MD 

20852, (301) 496–9666, rajasri.roy@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: December 17, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–30562 Filed 12–20–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Council on Drug Abuse. 

The meeting will be held as a virtual 

meeting and is open to the public, as 

indicated below. Individuals who plan 

to view the virtual meeting and need 

special assistance such as sign language 

interpretation or other reasonable 

accommodations to view the meeting, 

should notify Dr. Gillian Acca via email 

at gillian.acca@nih.gov five days in 

advance of the meeting. The open 

session will be videocast and can be 

accessed from the NIH Videocasting and 

Podcasting website (http://

videocast.nih.gov/). 

A portion of the meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The intramural programs 

and projects as well as the grant 

applications and/or contract proposals 

and the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with intramural 

programs and projects as well as the 

grant applications and/or contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council on Drug Abuse. 

Date: February 4, 2025. 

Closed: 10:30 a.m. to 11:45 a.m. 

Agenda: To review and evaluate grant 

applications. 

Closed: 11:45 a.m. to 12:15 p.m. 

Agenda: Report to Council from the NIDA 

Board of Scientific Counselors (BSC). 

Open: 1:00 p.m. to 5:00 p.m. 

Agenda: Presentations and other business 

of the Council. 

Address: National Institutes of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Susan R.B. Weiss, Ph.D., 

Director, Division of Extramural Research, 

Office of the Director, National Institute on 

Drug Abuse, NIH, Three White Flint North, 

RM 09D08, 11601 Landsdown Street, 

Bethesda, MD 20852, 301–443–6480, sweiss@

nida.nih.gov. 

Contact Person: Gillian Acca, Ph.D., Health 

Science Policy Analyst, Division of 

Extramural Research, Office of Extramural 

Policy, National Institute on Drug Abuse, 

NIH, Three White Flint North, RM 09C70, 


khammond on DSK9W7S144PROD with NOTICES